A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Royal Marsden NHS Foundation Trust
Centre Leon Berard
University of Michigan Rogel Cancer Center
University of Colorado, Denver
Oslo University Hospital
Oslo University Hospital
Northwestern University
University of Michigan Rogel Cancer Center
Institut Bergonié
University of Utah
Sanford Health
Sarcoma Oncology Research Center, LLC
Grupo Espanol de Investigacion en Sarcomas